141 related articles for article (PubMed ID: 8642473)
1. Homocysteine, EDRF, and endothelial function.
Upchurch GR; Welch GN; Loscalzo J
J Nutr; 1996 Apr; 126(4 Suppl):1290S-4S. PubMed ID: 8642473
[TBL] [Abstract][Full Text] [Related]
2. The vascular biology of S-nitrosothiols, nitrosated derivatives of thiols.
Upchurch GR; Welch GN; Loscalzo J
Vasc Med; 1996; 1(1):25-33. PubMed ID: 9546910
[TBL] [Abstract][Full Text] [Related]
3. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
Stamler JS; Osborne JA; Jaraki O; Rabbani LE; Mullins M; Singel D; Loscalzo J
J Clin Invest; 1993 Jan; 91(1):308-18. PubMed ID: 8380812
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.
Simon DI; Stamler JS; Jaraki O; Keaney JF; Osborne JA; Francis SA; Singel DJ; Loscalzo J
Arterioscler Thromb; 1993 Jun; 13(6):791-9. PubMed ID: 8388713
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
Bassenge E
Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine.
Stamler JS; Loscalzo J
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S202-4. PubMed ID: 1282970
[TBL] [Abstract][Full Text] [Related]
8. Biological chemistry and clinical potential of S-nitrosothiols.
Hogg N
Free Radic Biol Med; 2000 May; 28(10):1478-86. PubMed ID: 10927172
[TBL] [Abstract][Full Text] [Related]
9. Understanding the controversy over the identity of EDRF.
Feelisch M; te Poel M; Zamora R; Deussen A; Moncada S
Nature; 1994 Mar; 368(6466):62-5. PubMed ID: 8107883
[TBL] [Abstract][Full Text] [Related]
10. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Keaney JF; Simon DI; Stamler JS; Jaraki O; Scharfstein J; Vita JA; Loscalzo J
J Clin Invest; 1993 Apr; 91(4):1582-9. PubMed ID: 8473501
[TBL] [Abstract][Full Text] [Related]
11. Endothelial injury, vasoconstriction, and its prevention.
Loscalzo J
Tex Heart Inst J; 1995; 22(2):180-4. PubMed ID: 7647603
[TBL] [Abstract][Full Text] [Related]
12. S-Nitrosothiols: a class of nitric oxide-donor drugs.
Al-Sa'doni H; Ferro A
Clin Sci (Lond); 2000 May; 98(5):507-20. PubMed ID: 10781381
[TBL] [Abstract][Full Text] [Related]
13. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
Freedman JE; Frei B; Welch GN; Loscalzo J
J Clin Invest; 1995 Jul; 96(1):394-400. PubMed ID: 7615810
[TBL] [Abstract][Full Text] [Related]
14. A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium.
Sogo N; Wilkinson IB; MacCallum H; Khan SQ; Strachan FE; Newby DE; Megson IL; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):75-81. PubMed ID: 10945318
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of S-nitrosothiols: the role of nitric oxide.
Mathews WR; Kerr SW
J Pharmacol Exp Ther; 1993 Dec; 267(3):1529-37. PubMed ID: 7903392
[TBL] [Abstract][Full Text] [Related]
16. S-nitrosothiols and role of metal ions in decomposition to nitric oxide.
Williams DL
Methods Enzymol; 1996; 268():299-308. PubMed ID: 8782596
[No Abstract] [Full Text] [Related]
17. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
18. S-nitrosothiols: chemistry, biochemistry, and biological actions.
Upchurch GR; Welch GN; Loscalzo J
Adv Pharmacol; 1995; 34():343-9. PubMed ID: 8562444
[No Abstract] [Full Text] [Related]
19. Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet function.
Inbal A; Gurevitz O; Tamarin I; Eskaraev R; Chetrit A; Novicov I; Feldman M; Varon D; Eldar M; Loscalzo J
Blood; 1999 Sep; 94(5):1693-700. PubMed ID: 10477694
[TBL] [Abstract][Full Text] [Related]
20. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
Smith MP; Humphrey SJ; Kerr SW; Mathews WR
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
